https://www.capricor.com/investors/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/capricor/files/theme/images/logo-sm.png /investors Equisolve Investor Relations Suite https://www.capricor.com/investors/news-events/press-releases/detail/346/capricor-therapeutics-to-present-at-upcoming-investor Mon, 08 Jun 26 09:25:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/346/capricor-therapeutics-to-present-at-upcoming-investor https://www.capricor.com/investors/news-events/press-releases/detail/345/capricor-therapeutics-expands-commercial-leadership-team Thu, 28 May 26 21:55:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/345/capricor-therapeutics-expands-commercial-leadership-team https://www.capricor.com/investors/news-events/press-releases/detail/344/capricor-therapeutics-reports-first-quarter-2026-financial Tue, 12 May 26 16:05:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/344/capricor-therapeutics-reports-first-quarter-2026-financial https://www.capricor.com/investors/news-events/press-releases/detail/343/capricor-therapeutics-takes-legal-action-to-protect-patient Thu, 07 May 26 17:00:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/343/capricor-therapeutics-takes-legal-action-to-protect-patient https://www.capricor.com/investors/news-events/press-releases/detail/342/capricor-therapeutics-to-report-first-quarter-2026 Mon, 04 May 26 16:05:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/342/capricor-therapeutics-to-report-first-quarter-2026 https://www.capricor.com/investors/news-events/press-releases/detail/341/capricor-therapeutics-announces-late-breaking-presentation Wed, 22 Apr 26 09:00:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/341/capricor-therapeutics-announces-late-breaking-presentation https://www.capricor.com/investors/news-events/press-releases/detail/340/capricor-therapeutics-reports-fourth-quarter-and-full-year Thu, 12 Mar 26 16:01:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/340/capricor-therapeutics-reports-fourth-quarter-and-full-year https://www.capricor.com/investors/news-events/press-releases/detail/339/capricor-therapeutics-announces-late-breaking-hope-3-data Thu, 12 Mar 26 09:00:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/339/capricor-therapeutics-announces-late-breaking-hope-3-data https://www.capricor.com/investors/news-events/press-releases/detail/338/capricor-therapeutics-announces-establishment-of-new-pdufa Tue, 10 Mar 26 09:25:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/338/capricor-therapeutics-announces-establishment-of-new-pdufa https://www.capricor.com/investors/news-events/press-releases/detail/337/capricor-therapeutics-to-present-fourth-quarter-and-full Mon, 09 Mar 26 08:30:00 -0400 https://www.capricor.com/investors/news-events/press-releases/detail/337/capricor-therapeutics-to-present-fourth-quarter-and-full